Teladoc Investor Day Presentation Deck

Balance sheet as of December 31, 2019 Liquidity ($ in millions) Cash & marketable securities Debt Convertible notes 2022 Convertible notes 2025 Total Net Debt Note: Free cash flow represents cash flow from operations less capital expenditures Teladoc Maturity 12/15/22 5/15/25 HEALTH $517.1 Rate Outstanding 3.0% $275.0 1.4% $287.5 2.2% $562.5 $45.4 Teladoc Health, Inc Investor Day 2020 Liquidity highlights Solid progress in cash flow generation with Cash flow from operations for full year 2019 of $30M; free cash flow of $19M(¹) ● Anticipate utilizing ~$150M of cash for the pending In Touch Health acquisition Convertible notes mature over the longer term with well timed intervals. 132

View entire presentation